biomedicina slovenica

pr=Caserman : 43

  1. Obradović Davor; Gašperšič Rok; Caserman Simon; Leonardi Adrijana; Jamnik Maja; Podlesek Zdravko; Seme Katja; Anderluh Gregor; Križaj Igor; Maček Peter; Butala Matej
    A cytolethal distending toxin variant from Aggregatibacter actinomycetemcomitans
    2019 ►
  2. Cegnar Mateja; Podobnik Barbara; Gaberc-Porekar Vladka; Novak Štagoj Mateja; Jalen Špela; Komel Radovan; Caserman Simon
    Erythropoietin conjugates having oral bioavailability
    2015 ►
  3. Fidler Katarina; Premzl Aleš; Podobnik Barbara; Marušič Jaka; Jevševar Simona; Kunstelj Menči; Caserman Simon; Milunović Tatjana; Škrajnar Špela; Gaberc-Porekar Vladka
    Characterization of G-CSF dimers and their PEG-conjugates
    2009 ►
  4. Hribar Gorazd; Žnidaršič Andrej; Maver Uroš; Bele Marjan; Caserman Simon; Venturini Peter; Gaberc-Porekar Vladka
    Differenet types of nanoparticles decorated with TNF-[alpha] analogues
    2009 ►
  5. Anžur-Lasnik Marija; Hribar Gorazd; Caserman Simon; Gaberc-Porekar Vladka
    Fluorimetric method for quantitative evaluation of protein permeability in the Caco-2 cell in vitro model
    2009 ►
  6. Cajnko Miša Mojca; Marušič Maja; Caserman Simon; Anderluh Gregor
    LLO and Eqtll affect permeability and cell survival of Caco-2 cells
    2013 ►
  7. Marušić Maja; Zupančič Tina; Hribar Gorazd; Komel Radovan; Anderluh Gregor; Caserman Simon
    #The #Caco-2 cell culture model enables sensitive detection of enhanced protein permeability in the presence of N-decyl-[beta]-d-maltopyranoside
    2013 ►
  8. Cajnko Miša Mojca; Marušić Maja; Hribar Gorazd; Caserman Simon; Anderluh Gregor
    Equinatoxin II affects permeability of CaCO-2 monolayer
    2012 ►
  9. Hribar G; Žnidaršič A; Lenassi-Zupan A; Cerkovnik P; Milunović T; Maver U; Bele M; Caserman S; Novaković S; Gaberc-Porekar V
    Protein nanoparticles containing TNF-alpha analogs and their use in anti-cancer and anti-TNF therapy
    2011 ►
  10. Bergant Damijan; Hočevar Marko; Bešić Nikola; Glavač Damjan; Korošec Branka; Caserman Simon
    Hereditary medullary thyroid cancer in Slovenia - genotype-phenotype correlations
    2006 ►
  11. Caserman Simon; Kenig Saša; Sloane Bonnie F; Lah Tamara T
    Cathepsin L splice variants in human breast cell lines
    2006 ►
  12. Gole Boris; Duran-Alonso Maria Beatriz; Caserman Simon; Lah Tamara
    Expression of cathepsins and their inhibitors in U87 spheroids embedded in collagen matrices: characterisation of migrating versus non-migrating cells
    2006 ►
  13. Meager Anthony; Caserman Simon; Williams Stella; Gaines-Das Rose; Menart Viktor
    Evaluation of relative potencies of thermal degradation samples of the WHO international standard of interferon alpha 2b by antiviral assay and reposter gene assay
    2005 ►
  14. Lah Tamara T; Zajc Irena; Strojnik Tadej; Kenig Saša; Caserman Simon; Trinkaus Miha; Martin Pierre-Marie
    Multifunctional cathepsin L as potential target of cancer therapy
    2005 ►
  15. Caserman Simon; Kenig Saša; Lah Tamara T
    High expression of cathepsin L-A3 splice variant in invasive breast cancer cell lines
    2005 ►
  16. Caserman S; Lah TT
    Comparison of expression of cathepsins B and L and MMP2 in andothelial cells and in capillary sprouting in collagen gel
    2004 ►
  17. Caserman Simon
    Vloga proteoliznih encimov pri invazivni rasti endotelijskih celic med procesom angiogeneze
    2004 ►
  18. Caserman Simon; Lah Tamara
    Comparison of expression of cathepsins B and L and MMP-2 in endothelial cells and in aorta ring model of angiogenesis
    2004 ►
  19. Caserman Simon; Trinkaus Miha; Sever Nataša; Zajc Irena; Lah Tamara
    Multiple functions of lysosomal proteolytic anzymes in cancer
    2003 ►
  20. Caserman Simon; Fonda Irena; Gaberc-Porekar Vladka; Kenig Maja; Lah Tamara; Menart Vinko
    TNF-alpha analog LK-805: heparan sulphate dependent cytotoxicity on L-929 mouse tumor cell line and reduced inhibitory effect on in vitro capillary growth
    2003 ►
  21. Korošec B; Caserman S; Bergant D; Ravnik-Glavač M; Glavač D
    Mutational analyses of the ret proto-oncogene in Slovenian Men2 families
    2001 ►
  22. Korošec B; Caserman S; Bergant D; Ravnik-Glavač M; Glavač D
    Mutational analyses of the RET proto-encogene in Slovenian MEN2 families
    2003 ►
  23. Caserman Simon
    Mutacije v RET onkogenu pri slovenskih bolnikih z multiplo endokrinopatijo tipa 2: korelacija med genotipom in fenotipom
    2000 ►
  24. Caserman Judita; Mrvič Tatjana
    Naravna žarišča klopov v Sloveniji, klopni meningoencefalitis in Lyme borelioza
    1990 ►
  25. Glavač D; Caserman S; Bergant D; Ravnik-Glavač M
    Mutations in the RET proto-oncogene in Slovenian families with multiple endocrine neoplasia type 2
    2000 ►
  26. Glavač D; Gorinšek B; Caserman S; Potočnik U; Ravnik-Glavač M
    K-ras and p53 mutations in colorectal tumors
    2000 ►
  27. Gorinšek B; Caserman S; Potočnik U; Ravnik-Glavač M; Glavač D
    P53 and K-ras mutations in colorectal tumors with high microsatellite instability
    2000 ►
  28. Glavač D; Masera A; Ovčak Z; Potočnik U; Caserman S; Ravnik-Glavač M
    Molecular genetic analysis of tumor supressor genes and oncogenes in sporadic renal cell carcinoma
    2000 ►
  29. Glavač D; Caserman S; Gorinšek B; Bergant D; Ravnik-Glavač M
    Molecular genetic analysis of Slovenian families with hereditary multiple endocrine neoplasia type 2 (MEN 2A, MEN 2B and FMTC)
    2000 ►
  30. Glavač Damjan; Gorinšek Benjamin; Caserman Simon; Potočnik Uroš; Ravnik-Glavač Metka
    K-ras and P53 mutations in colorectal tumors and replication error (RER+) phenotype
    1999 ►
  31. Gorinšek Benjamin; Caserman S; Potočnik U; Ravnik-Glavač M; Glavač D
    K-ras and p53 mutations in colorectal tumours and replication error (RER+) phenotype
    1999 ►
  32. Caserman Simon; Gorinšek B; Bergant D; Ravnik-Glavač M; Glavač D
    C618R mutation in the RET proto-oncogene in a Slovenian kindred with a medulary thyroid carcinoma (FMTC) and Hirschprung disease
    1999 ►
  33. Glavač D; Mašera A; Ovčak Z; Potočnik U; Caserman S; Ravnik-Glavač M
    Molecular genetic analysis of tumor supressor genes and oncogenes in sporadic renal cell tumors
    1999 ►
  34. Volavšek M; Potočnik U; Caserman S; Kambič S; Ravnik-Glavač M; Glavač M; Gale N
    Molecular changes in squamous carcinoma of the head and neck in slovenian patients
    1999 ►
  35. Caserman S; Rott T; Ravnik-Glavač M; Eržen J; Glavač D
    Molecular abnormalities in lung cancer
    1999 ►
  36. Volavšek M; Potočnik U; Caserman S; Kambič V; Ravnik-Glavač M; Glavač D; Gale N
    Molecular genetic analysis of the head and neck carcinoma in Slovenian patients
    1999 ►
  37. Glavač Damjan; Mašera Andrej; Ovčak Zdenka; Potočnik Uroš; Caserman Simon; Ravnik-Glavač Metka
    Molecular genetic analysis of tumor supressor genes and oncogenes in sporadic renal cell tumors
    1999 ►
  38. Gorišek Benjamin; Caserman Simon; Potočnik Uroš; Ravnik-Glavač Metka; Glavač Damjan
    Mutations of P53, K-ras in colorectal tumors and replication error phenotype
    1999 ►
  39. Caserman Simon; Gorinšek Benjamin; Bergant Damijan; Ravnik-Glavač Metka; Glavač Damjan
    C618R mutation in the RET proto-oncogene in a Slovenian kindred with a familial medulary thyroid carcinoma (FMTC) and hirschsprung disease
    1999 ►
  40. Glavač D; Bergant D; Caserman S; Gorinšek B; Ravnik-Glavač M
    Molecular genetic analysis of RET-receptor tyrosine kinease gene mutations in different neoplastic phenotypes
    1998 ►
  41. Ravnik-Glavač M; Gorinšek B; Caserman S; Potočnik U; Glavač D
    K-ras and p53 mutations in colorectal tumors and replication error (RER+) phenotype
    1998 ►
  42. Caserman G; Baraga D
    Informacijski sistem za spremljanje sistematskih pregledov šolskih otrok
    [Information sistem for monitoring of systematic medical exanimation of school children]
    1994 ►
  43. Caserman S
    Vloga Ca2+ pri indukciji oksidativnega metabolizma v očesu muhe Calliphora erythrocephala (Meigen): respirometrične meritve izolirane retine muhe
    [Calcium dependent induction of oxygen consumption in the eye of Calliphora erythrocephala (Meigen)]
    1994 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics